Ignota Labs
PrivateLast Round
Seed
Feb 26, 2025
Total Funding Raised
$6.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ignota Labs operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Seed round in February 2025.
Ignota Labs is a biotechnology company that utilizes its proprietary AI platform, SAFEPATH, to identify and mitigate toxicity issues in promising drugs that were abandoned during clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ignota Labs Comparables
Compare Ignota Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sentinus.AI | 86% | |
| DeepCyte | 80% | |
| Biossil Inc. | 78% |
For institutional investors. Book with your work email.
Ignota Labs Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ignota Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Montage Ventures | Seed |
| Gaingels | Seed |
| Blue Wire Capital | Seed |
| Modi Ventures | Seed |
| AIX Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 31% MoM, reaching 3.3K.
- Feb 26, 2025
$7M raised in Seed round.
For institutional investors. Book with your work email.
Ignota Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ignota Labs's valuation, stock price, and market status.
Is Ignota Labs a public or private company?
Ignota Labs is a private company.
What is the current stock price of Ignota Labs?
Ignota Labs is a private company, so its shares have no public market price. Caplight tracks Ignota Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ignota Labs worth (valuation)?
Valuation information for Ignota Labs is not publicly available.
Can I buy Ignota Labs stock?
Ignota Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ignota Labs's last funding round?
Ignota Labs's most recent funding round was Seed on February 26, 2025.
Who are the main investors in Ignota Labs?
Key investors in Ignota Labs include Montage Ventures, AIX Ventures.
Will Ignota Labs IPO soon?
No public IPO plans have been announced for Ignota Labs.
How can I track Ignota Labs secondary market activity?
Caplight tracks bids, offers, and trades in Ignota Labs's shares on secondary markets.